SLE mortality remains disproportionately high, despite improvements over the last decade
Open Access
- 1 September 2018
- journal article
- editorial
- Published by SAGE Publications in Lupus
- Vol. 27 (10), 1577-1581
- https://doi.org/10.1177/0961203318786436
Abstract
Despite a marked improvement in 10-year survival for systemic lupus erythematosus (SLE) patients over the past five decades, mortality rates from SLE remain high compared to those in the general population. SLE was also among the leading causes of death in young women in the United States during 2000-2015. However, it is encouraging that SLE mortality rates and the ratios of SLE mortality rates to non-SLE mortality rates have decreased every year since the late 1990s. Despite this improvement, disparities in SLE mortality persist according to sex, race, age, and place of residence. Furthermore, demographic and geographic variables seem to modify the effect of each other in influencing SLE mortality, leading to interactions between sex/race/ethnicity-associated factors and geographic differences. In other words, individuals of the same sex/race/ethnicity had differences in SLE mortality depending on where they lived. These observations highlight SLE as an important public health issue. The recognition of SLE as a leading cause of death in the general population might spur targeted public health programs and research funding to address the high lupus mortality.Keywords
Funding Information
- National Institutes of Health
This publication has 24 references indexed in Scilit:
- Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysisLupus, 2016
- Overall and Cause‐Specific Mortality in Patients With Systemic Lupus Erythematosus: A Meta‐Analysis of Observational StudiesArthritis Care & Research, 2013
- Systemic Lupus Erythematosus in Northwestern SpainMedicine, 2011
- Changing Patterns in Mortality and Disease Outcomes for Patients with Systemic Lupus ErythematosusThe Journal of Rheumatology, 2008
- Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992Arthritis & Rheumatism, 1999
- Intermittent intravenous pulse cyclophosphamide treatment in systemic lupus erythematosus.1992
- Azathioprine in the treatment of systemic lupus erythematosus. A controlled studyArthritis & Rheumatism, 1971
- Cyclophosphamide in Lupus Nephritis: A Controlled TrialAnnals of Internal Medicine, 1971
- PLAQUENIL IN THE TREATMENT OF LUPUS ERYTHEMATOSUSJournal of the American Medical Association, 1956
- NATURAL HISTORY OF LUPUS ERYTHEMATOSUS DISSEMINATUSAnnals of Internal Medicine, 1953